Institutional Investors Double Down on Philip Morris Transformation

While retail investors continue to shy away from traditional tobacco equities, major financial institutions are placing significant bets on Philip Morris International’s strategic pivot. Behind the scenes, a substantial repositioning is underway as heavyweight funds dramatically increase their exposure to the tobacco giant, whose own transformation strategy appears to be gaining traction.

Financial Performance Exceeds Expectations

Philip Morris delivered stronger-than-anticipated second-quarter 2025 results, with earnings per share reaching $1.91 compared to analyst projections of $1.86. The company’s performance was particularly notable in its smoke-free division, which expanded by 15.2% and now represents 41% of total revenue. This growth trajectory prompted management to raise full-year 2025 EPS guidance to a range between $7.43 and $7.56, representing expected growth of 13-15%.

The smoke-free product category continues to demonstrate remarkable momentum. Heated tobacco devices including the IQOS system are achieving double-digit growth rates, while ZYN nicotine pouches have surged by more than 50% in the United States market.

Major Funds Amplify Their Positions

Institutional confidence in Philip Morris has manifested through substantial position increases across multiple major investment firms. Blue Whale Capital expanded its holding by 5.6%, elevating Philip Morris to become its sixth-largest portfolio position. Even more significantly, 1832 Asset Management executed a massive 475.5% increase in its stake during the first quarter of 2025, acquiring over one million additional shares valued at approximately $210 million.

Should investors sell immediately? Or is it worth buying Philip Morris?

Vanguard, the investment management giant, also raised its position by 0.9% and now maintains holdings worth more than $22 billion. Collectively, institutions and hedge funds control a substantial 78.63% of outstanding shares, indicating strong professional investor belief in the company’s long-term viability.

Wall Street Maintains Bullish Outlook

Market analysts remain overwhelmingly positive about Philip Morris’s prospects. Among thirteen covering firms, twelve maintain “Buy” recommendations with only one advising investors to “Hold.” The average price target stands at $186.27, with the most optimistic projections reaching as high as $220 per share. Throughout July and August, multiple financial institutions either initiated or reaffirmed their positive ratings on the company.

The convergence of institutional accumulation, strong financial performance, and analyst optimism suggests that professional investors have already reached their verdict on Philip Morris’s transformation strategy. The company now faces the task of executing its smoke-free vision to convince any remaining skeptics in the market.